Home » Topics » BioWorld Science

BioWorld Science
RSS

INTH-454: A small molecule modulator of the p300/CBP interactome for cancer

Oct. 31, 2019

(R)-[18F]MH.MZ as a novel PET tracer for the detection of 5-HT2A receptors in the human brain

Oct. 31, 2019

Topline results presented from phase III CMS-001 study of amifampridine phosphate

Oct. 31, 2019

Cyclerion Therapeutics presents topline data from two phase II studies of praliciguat

Oct. 31, 2019

Telix and AusHealth sign agreement for APOMAB molecularly targeted radiation platform

Oct. 31, 2019

SOX9 antagonist Z-02 may improve spinal cord injury

Oct. 31, 2019

New compounds block Tat binding to human DAT for HAND treatment

Oct. 31, 2019

MPST a potential new biomarker in hepatocellular carcinoma

Oct. 31, 2019

Encouraging phase II results reported for VPX-638

Oct. 31, 2019

Cirrhosis to liver cancer progression still mysterious

Oct. 31, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...